Paul Treacy, SVP, Technical Operations at Jazz Pharmaceuticals plc (JAZZ), sold 2,408 shares at $143.30 ($345K) on 2017-08-14, disclosed to the SEC on 2017-08-15.
Seasonal sale ($345k) by SVP, Technical Operations — this insider has traded JAZZ in August in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $143.30 | 1,104 | $158K | 45.8% |
| 2 | $143.30 | 1,104 | $158K | 45.8% |
| 3 | $143.41 | 200 | $29K | 8.3% |
| Total | $143.31 avg | 2,408 | $345K | 100% |
| Filing → |
| JAZZ | SELL | 2019-03-04 | $195K | — | Filing → |
| JAZZ | SELL | 2018-08-13 | $462K | — | Filing → |
| JAZZ | SELL | 2018-03-07 | $168K | — | Filing → |